CLIO Cosmetics Co.,Ltd

KOSDAQ:A237880 Stock Report

Market Cap: ₩317.2b

CLIO CosmeticsLtd Balance Sheet Health

Financial Health criteria checks 6/6

CLIO CosmeticsLtd has a total shareholder equity of ₩232.2B and total debt of ₩1.4B, which brings its debt-to-equity ratio to 0.6%. Its total assets and total liabilities are ₩305.4B and ₩73.2B respectively. CLIO CosmeticsLtd's EBIT is ₩36.1B making its interest coverage ratio -9.9. It has cash and short-term investments of ₩141.6B.

Key information

0.6%

Debt to equity ratio

₩1.42b

Debt

Interest coverage ratio-9.9x
Cash₩141.57b
Equity₩232.21b
Total liabilities₩73.22b
Total assets₩305.43b

Recent financial health updates

Recent updates

CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Price Is Out Of Tune With Earnings

Oct 08
CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Price Is Out Of Tune With Earnings

If EPS Growth Is Important To You, CLIO CosmeticsLtd (KOSDAQ:237880) Presents An Opportunity

Jun 26
If EPS Growth Is Important To You, CLIO CosmeticsLtd (KOSDAQ:237880) Presents An Opportunity

What CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 27% Share Price Gain Is Not Telling You

May 25
What CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 27% Share Price Gain Is Not Telling You

The Strong Earnings Posted By CLIO CosmeticsLtd (KOSDAQ:237880) Are A Good Indication Of The Strength Of The Business

May 21
The Strong Earnings Posted By CLIO CosmeticsLtd (KOSDAQ:237880) Are A Good Indication Of The Strength Of The Business

We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)

Apr 24
We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)

Some Shareholders Feeling Restless Over CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E Ratio

Is CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 1.0% Dividend Worth Your Time?

Apr 13
Is CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 1.0% Dividend Worth Your Time?

When Should You Buy CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Mar 30
When Should You Buy CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Here's Why CLIO CosmeticsLtd (KOSDAQ:237880) Can Manage Its Debt Responsibly

Mar 16
Here's Why CLIO CosmeticsLtd (KOSDAQ:237880) Can Manage Its Debt Responsibly

Does This Valuation Of CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Imply Investors Are Overpaying?

Mar 02
Does This Valuation Of CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Imply Investors Are Overpaying?

CLIO CosmeticsLtd's (KOSDAQ:237880) Shareholders Are Down 47% On Their Shares

Feb 17
CLIO CosmeticsLtd's (KOSDAQ:237880) Shareholders Are Down 47% On Their Shares

Does CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Feb 02
Does CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

What Type Of Shareholders Make Up CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Share Registry?

Jan 18
What Type Of Shareholders Make Up CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Share Registry?

Are Dividend Investors Making A Mistake With CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Jan 05
Are Dividend Investors Making A Mistake With CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Should You Think About Buying CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Now?

Dec 23
Should You Think About Buying CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Now?

Are CLIO CosmeticsLtd's (KOSDAQ:237880) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dec 08
Are CLIO CosmeticsLtd's (KOSDAQ:237880) Statutory Earnings A Good Reflection Of Its Earnings Potential?

CLIO CosmeticsLtd (KOSDAQ:237880) Seems To Use Debt Rather Sparingly

Nov 25
CLIO CosmeticsLtd (KOSDAQ:237880) Seems To Use Debt Rather Sparingly

Financial Position Analysis

Short Term Liabilities: A237880's short term assets (₩198.0B) exceed its short term liabilities (₩58.8B).

Long Term Liabilities: A237880's short term assets (₩198.0B) exceed its long term liabilities (₩14.4B).


Debt to Equity History and Analysis

Debt Level: A237880 has more cash than its total debt.

Reducing Debt: A237880's debt to equity ratio has reduced from 9% to 0.6% over the past 5 years.

Debt Coverage: A237880's debt is well covered by operating cash flow (2517.1%).

Interest Coverage: A237880 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 06:13
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CLIO Cosmetics Co.,Ltd is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mijin JoCape Investment & Securities Co., Ltd.
Eun Jung ParkDaishin Securities Co. Ltd.
Hyungwook ChoiDaiwa Securities Co. Ltd.